Log in or Sign up for Free to view tailored content for your specialty!
Pulmonary Vascular Disease News
Low income linked to more severe chronic thromboembolic pulmonary hypertension
HONOLULU — Patients with chronic thromboembolism pulmonary hypertension and a higher median income had better 6-minute walk distance and hemodynamics than those with a low income, according to a presentation at the CHEST Annual Meeting.
Diabetes may raise odds for mortality in pulmonary hypertension
HONOLULU — Patients with pulmonary hypertension who also had diabetes showed increased likelihood for mortality compared with patients without diabetes, according to a systemic review presented at the CHEST Annual Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
ARDS plus pulmonary hypertension raises odds for mortality, longer hospital stay
HONOLULU — Patients with pulmonary hypertension hospitalized with acute respiratory distress syndrome had increased odds for mortality, extended stays and higher costs, according to research presented at the CHEST Annual Meeting.
Higher comorbidity burden raises odds for in-hospital mortality in patients with PE
HONOLULU — A higher comorbidity burden increases the odds for in-hospital mortality among adults with pulmonary embolism, according to a poster presented at the CHEST Annual Meeting.
FDA grants priority review to sotatercept for pulmonary arterial hypertension
The FDA has granted priority review to sotatercept, a novel activin signaling inhibitor designed to treat adults with pulmonary arterial hypertension, according to a manufacturer-issued press release.
Ultrasound lowers diagnostic imaging referral in suspected PE, but has high failure rate
Referral to diagnostic imaging decreased with use of an ultrasound protocol in patients with suspected pulmonary embolism, according to a presentation at the European Respiratory Society International Congress.
Flu season ups CV risk, not reduced by higher-dose vaccine in already high-risk patients
Local influenza spread was associated with temporary increased CV risk, but flu vaccine dose — high or standard — did not prevent hospitalization for cardiopulmonary events or all-cause death in high-risk patients, researchers reported.
Sotatercept expected to raise life expectancy, lower hospitalizations in PAH
Patients with pulmonary arterial hypertension receiving sotatercept, a novel activin signaling inhibitor, plus background therapy are expected to live longer, according to a European Respiratory Society International Congress presentation.
One in 10 patients in cardiac ICU uses recreational drugs; half fail to disclose it
Use of recreational drugs such as cannabis, opioids, cocaine and amphetamines was prevalent in 11% of patients admitted to French cardiac ICUs and tied to increased odds of in-hospital major adverse events, researchers reported.
Workshop aims to expand use of point-of-care ultrasonography
With its noninvasive and portable nature, point-of-care ultrasonography is an emerging technological tool for critical care clinicians when diagnosing and caring for patients.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read